Cresco Labs (XCNQ:CL) Cyclically Adjusted PB Ratio: (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XCNQ:CL Cresco Labs Inc XCNQ:CL
63 GF Score
Price C$1.04
GF Value C$1.22
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cresco Labs Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cresco Labs  (XCNQ:CL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cresco Labs Cyclically Adjusted PB Ratio Related Terms


Cresco Labs Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Cresco Labs's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Cyclically Adjusted PB Ratio Chart

Cresco Labs Annual Data
Trend Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cresco Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XCNQ:CL vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted PB Ratio falls into.


XCNQ:CL
63GF Score
Cresco Labs Inc XCNQ:CL
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cresco Labs Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cresco Labs's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Cresco Labs's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.352/333.9520*333.9520
=1.352

Current CPI (Jun. 2026) = 333.9520.

Cresco Labs Quarterly Data

Book Value per Share CPI Adj_Book
201607 -31.657 240.628 -43.935
201610 -31.571 241.729 -43.616
201701 -34.686 242.839 -47.700
201704 -34.486 244.524 -47.098
201707 -36.257 244.786 -49.464
201710 -35.457 246.663 -48.005
201801 -37.771 247.867 -50.889
201804 -37.943 250.546 -50.574
201807 -34.257 252.006 -45.397
201810 -0.317 252.885 -0.419
201903 1.440 254.202 1.892
201906 1.367 256.143 1.782
201909 1.760 256.759 2.289
201912 1.873 256.974 2.434
202003 4.235 258.115 5.479
202006 3.891 257.797 5.040
202009 3.735 260.280 4.792
202012 2.713 260.474 3.478
202103 3.167 264.877 3.993
202106 4.032 271.696 4.956
202109 3.101 274.310 3.775
202112 3.327 278.802 3.985
202203 3.138 287.504 3.645
202206 3.425 296.311 3.860
202209 3.497 296.808 3.935
202212 2.828 296.797 3.182
202303 2.753 301.836 3.046
202306 2.463 305.109 2.696
202309 2.029 307.789 2.201
202312 1.997 306.746 2.174
202403 1.991 312.332 2.129
202406 1.844 314.175 1.960
202409 1.780 315.301 1.885
202412 1.941 315.605 2.054
202503 1.881 319.799 1.964
202506 1.709 322.561 1.769
202509 1.658 324.800 1.705
202512 1.306 324.054 1.346
202603 1.244 330.213 1.258
202606 1.352 333.952 1.352

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cresco Labs (XCNQ:CL) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of C$1.04 is trading 14.8% below its estimated GF Value™ of C$1.22. GuruFocus considers Cresco Labs to be Modestly Undervalued.

Key valuation signals for XCNQ:CL:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: C$1.22 vs. price of C$1.04 (14.8% below fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the XCNQ:CL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cresco Labs Business Description

Other Exchanges CRLBF:USA6CQ:Germany
Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
63GF Score

Get the complete analysis for XCNQ:CL

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.04
Price
C$1.22
GF Value